1. Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma
- Author
-
Halis Simsek, Hikmet Akkiz, Anıl Delik, Harika Gozukara Bag, Hatice Yasemin Balaban, Nazım Ekin, Brian I. Carr, Kendal Yalcin, Yakup Ülger, Oğuz Üsküdar, Ahmet Uyanikoglu, Ayhan Balkan, Sedef Kuran, Burak Güney, Ümit Karaoğullarından, Ayşegül Özakyol, and Engin Altintaş
- Subjects
medicine.medical_specialty ,Carcinoma, Hepatocellular ,Inflammation ,030204 cardiovascular system & hematology ,Gastroenterology ,Carcinogenic process ,Article ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Albumins ,medicine ,Humans ,In patient ,030212 general & internal medicine ,Retrospective Studies ,Tumor size ,business.industry ,Liver Neoplasms ,Albumin ,Patient survival ,General Medicine ,medicine.disease ,Portal vein thrombosis ,C-Reactive Protein ,Hepatocellular carcinoma ,medicine.symptom ,business ,Biomarkers - Abstract
Introduction Hepatocellular carcinoma is associated with several chronic inflammatory conditions. It is increasingly understood that the inflammation may be part of the carcinogenic process and prognostically important. Objective To evaluate the serum levels of three inflammation markers in relation to survival in HCC patients. Methods We retrospectively examined the serum levels of CRP, albumin and ESR, both singly and in combination, in relation to patient survival. Results Survival worsened with increase in CRP or ESR or decrease in albumin levels. Combinations of CRP plus albumin or CRP plus ESR were associated with an even greater range of survival (3-fold), together with significant differences in maximum tumor diameter (PVT) and percent of patients with portal vein thrombosis (PVT). The triplet of CRP plus albumin plus ESR was associated with a sevenfold difference in survival, comparing low vs high parameter levels. These significant differences were found in patients with small or large tumors. Conclusions Combinations of CRP with albumin or ESR or all three parameters together significantly related to differences in survival and to differences in MTD and percent PVT, in patients with both small and large size HCCs.
- Published
- 2020